Mark Fishman
Mark Fishman | |
|---|---|
| Alma mater | Yale College, Harvard Medical School |
| Known for | pioneering Zebrafish research in cardiology |
| Awards | Institute of Medicine member, Fellow of the American Academy of Arts and Sciences |
| Scientific career | |
| Fields | Medicine, Cardiology |
| Institutions | Novartis Institutes of BioMedical Research, Massachusetts General Hospital, Harvard Medical School |
Mark Fishman is a noted researcher and clinician in cardiology and the previous President of the Novartis Institutes for BioMedical Research (NIBR),[1] the main research arm of Novartis Pharmaceuticals with over 6,700 employees and a 2012 budget of more than $9B.[2]
Fishman was appointed President of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.[3] He is the author of over 100 publications[4] and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.[5][6][7]
Education
- B.A. Yale College, 1972
- M.D. Harvard Medical School, 1976
Career
He was previously a Professor of Medicine at Harvard Medical School, Chief of Cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.[8]
References
- ^ http://www.novartis.com/about-novartis/people/executive-committee.shtml
- ^ http://www.novartis.com/newsroom/fact-sheet.shtml
- ^ http://www.prdomain.com/companies/N/Novartis/newsreleases/20025718532.htm
- ^ http://www.pubmed.gov 183 results as of 20 Oct 2009
- ^ http://physiolgenomics.physiology.org/cgi/content/full/2/2/49
- ^ http://people.forbes.com/profile/mark-c-fishman/58785
- ^ http://www.baderc.org/bios/FishmanBios.pdf
- ^ http://www.novartis.com/downloads/newsroom/corporate-press-kit/7g_CV_Mark_C_Fishman_EN.pdf